|Articles|April 7, 2015

ChemDAQ Agreement with SciCan Expands Sterilant Vapor Detection in Canadian Hospitals

ChemDAQ Inc., a leader in environmental monitoring systems for low-temperature and liquid chemical sterilants, announces a distribution agreement with SciCan Ltd., a full spectrum infection control solution provider. SciCan will offer ChemDAQ’s Steri-Trac® line of environmental monitoring systems for peracetic acid, hydrogen peroxide, ozone and ethylene oxide vapors. This agreement signifies a major step within the Canadian hospital market, enabling hospitals to comply with CSA Standards, provincial regulations, and the Canadian Centre for Occupational Health and Safety (CCOHS) regulations.

Modern sterilizers are made to very high standards, however, normal wear and tear, user error and failure of engineering controls can, and does, occur. Continuous monitoring is the only way to immediately detect levels of toxic vapors to which employees are exposed.

Dave Hilliker, CEO of ChemDAQ says, “Continuous monitoring for chemical vapors in sterile processing departments is critically important for workers. Without monitoring these toxic chemical vapors sterile processing professionals simply don’t know what their exposure level is. If they don’t know, then they’re at risk and not compliant with safety regulations. Anyone working within a sterile processing department is at risk of exposure.  SciCan recognizes the need to keep sterile processing professionals safe and compliant by monitoring chemical vapor levels.”

ChemDAQ’s mission is to ensure the safe and continued use of biocidal chemicals, which aligns perfectly with SciCan’s mission to provide safe, effective products to sterile processing departments.

“SciCan Medical remains at the forefront of efforts to provide Sterile Processing Departments with the most innovative, effective and safest products available on the market. This agreement highlights our determination to go further in the protection of hospital workers in Canada” says Patrick Hennessy, director of medical sales, North America at SciCan Ltd.

Source: ChemDAQ, Inc.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.